63 related articles for article (PubMed ID: 15133497)
1. v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype.
Iacovoni JS; Cohen SB; Berg T; Vogt PK
Oncogene; 2004 Jul; 23(33):5703-6. PubMed ID: 15133497
[TBL] [Abstract][Full Text] [Related]
2. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Cohen SB; Waha A; Gelman IH; Vogt PK
Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
[TBL] [Abstract][Full Text] [Related]
3. Characterization of sarcoma cell lines from v-jun transgenic mice.
Marshall GM; Vanhamme L
Cancer Res; 1993 Feb; 53(3):622-6. PubMed ID: 8425197
[TBL] [Abstract][Full Text] [Related]
4. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
5. Jun, the oncoprotein.
Vogt PK
Oncogene; 2001 Apr; 20(19):2365-77. PubMed ID: 11402333
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells.
Van Amsterdam JR; Wang Y; Sullivan RC; Zarbl H
Oncogene; 1994 Oct; 9(10):2969-76. PubMed ID: 8084600
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
8. Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts.
Marshall H; Popowicz P; Engel G; Martens I; Linder S
Oncogene; 1993 May; 8(5):1303-9. PubMed ID: 8479751
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-1 is a negative target of v-Jun overexpression.
Hadman M; Lin W; Bush L; Bos TJ
Oncogene; 1998 Feb; 16(5):655-60. PubMed ID: 9482111
[TBL] [Abstract][Full Text] [Related]
10. Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine tumor model.
Brem R; Certa U; Neeb M; Nair AP; Moroni C
Oncogene; 2001 May; 20(22):2854-8. PubMed ID: 11420697
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype.
Kowara R; Karaczyn A; Cheng RY; Salnikow K; Kasprzak KS
Toxicol Appl Pharmacol; 2005 May; 205(1):1-10. PubMed ID: 15885260
[TBL] [Abstract][Full Text] [Related]
13. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
14. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-regulated gene expression in mammary carcinoma cells.
Amin DN; Tuck D; Stern DF
Exp Cell Res; 2005 Sep; 309(1):12-23. PubMed ID: 15963498
[TBL] [Abstract][Full Text] [Related]
16. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
17. JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
Caffarel MM; Moreno-Bueno G; Cerutti C; Palacios J; Guzman M; Mechta-Grigoriou F; Sanchez C
Oncogene; 2008 Aug; 27(37):5033-44. PubMed ID: 18454173
[TBL] [Abstract][Full Text] [Related]
18. v-Jun downregulates the alpha 2 (I) collagen target gene indirectly through Sp1/3.
Chamboredon S; Castellazzi M
Oncogene; 2005 Apr; 24(15):2547-57. PubMed ID: 15735704
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets of the oncogenic transcription factor jun.
Hartl M; Bader AG; Bister K
Curr Cancer Drug Targets; 2003 Feb; 3(1):41-55. PubMed ID: 12570660
[TBL] [Abstract][Full Text] [Related]
20. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
